methylphenidate

(redirected from Ritalin la)
Also found in: Dictionary, Thesaurus.

methylphenidate

 [meth″il-fenĭ-dāt]
a mild central nervous system stimulant; the hydrochloride salt is administered orally in the treatment of attention-deficit/hyperactivity disorder and narcolepsy.

methylphenidate

/meth·yl·phen·i·date/ (meth″il-fen´ĭ-dāt) a central stimulant, used in the form of the hydrochloride salt in the treatment of attention-deficit in children and narcolepsy.

methylphenidate

(mĕth′əl-fĕn′ĭ-dāt′, -fē′nĭ-)
n.
A drug, C14H19NO2, chemically related to amphetamine, that acts as a mild stimulant of the central nervous system and is used in its hydrochloride form to treat attention deficit hyperactivity disorder and narcolepsy.

methylphenidate

An amphetamine-derived CNS stimulant.
 
Adverse effects
Decreased appetite—10–15% of children have major weight loss; insomnia—most suffer sleep delay; abdominal pain; headaches; dry mouth; dizziness; depression, tachycardia; a proposed link to decreased growth is uncertain.
 
Indications for
Hyperactivity, ADD, childhood narcolepsy.

methylphenidate

Ritalin® Neuropharmacology An amphetamine derived CNS stimulant used to control ADD and hyperactivity in children Adverse effects ↓ Appetite, 10-15% of children have major weight loss; insomnia–most suffer sleep delay, abdominal pain, headaches, dry mouth, dizziness, depression, tachycardia; link with ↓ growth is uncertain Used for Hyperactivity; narcolepsy; ADD. See Amphetamine.

methylphenidate

A nervous system stimulant drug that, paradoxically, has been found effective in the management of ATTENTION-DEFICIT HYPERACTIVITY DISORDER in children. A brand name is Ritalin. The current consensus of opinion on the use of this drug for this purpose is that it is grossly over-prescribed, especially in the USA.

methylphenidate

a central nervous system stimulant used in the treatment of hyperkinesis and narcolepsy in dogs.
References in periodicals archive ?
Celgene Corporation (Nasdaq: CELG) of Warren, New Jersey granted Novartis Pharma AG an exclusive worldwide (excluding Canada) license covering its intellectual property rights associated with Ritalin LA as well as Focalin.
Silva and his colleagues compared Concerta 18 mg, Concerta 36 mg, and Ritalin LA 20 mg vs.
Each bead-filled capsule of Ritalin LA provides an immediate release of Ritalin for rapid onset of action, and a second release of the medication approximately four hours after administration.
Parent, teacher, and investigator assessments found significantly greater improvements in ADHD symptoms in the Ritalin LA group compared with placebo.
Ritalin LA (methylphenidate hydrochloride) extended-release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
Ritalin LA and Focalin XR were developed with SODAS(R) technology (spheroidal oral drug absorption system), a multiparticulate drug delivery system of Elan Corporation, plc .
Ritalin LA and Focalin XR were developed with spheroidal oral drug absorption system (SODAS), a multiparticulate drug delivery system of Elan Corporation, plc .
In the study, Ritalin LA helped improve ADHD symptoms in adolescent girls including attention and behavior.
Celgene licensed the worldwide rights (excluding Canada) to Focalin to Novartis Pharma AG in exchange for milestone payments and royalties on Focalin and the entire Ritalin family of drugs including Ritalin, Ritalin LA, Ritalin SR and ultimately Focalin LA.
Girls, Ritalin LA, and ADHD: A Controlled Evaluation) - to evaluate the efficacy and safety of Ritalin(R) LA (methylphenidate HCL) extended release capsules in girls aged 12-17.
A new study comparing two long-acting treatments found that a medication called Ritalin LA may provide important benefits, especially during the critical morning hours.
Girls, Ritalin LA, and ADHD: A Controlled Evaluation), the study is designed to evaluate the clinical effects of Ritalin LA vs.